| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0069-8032(07)45007-0 |
| P50 | author | Adriano Aguzzi | Q375410 |
| P2860 | cites work | Lymphoid neogenesis in rheumatoid synovitis | Q74147962 |
| Branched polyamines cure prion-infected neuroblastoma cells | Q24529092 | ||
| NMR structure of the human doppel protein | Q27640537 | ||
| Impaired prion replication in spleens of mice lacking functional follicular dendritic cells | Q28144723 | ||
| Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel | Q28145970 | ||
| Virus interference. I. The interferon | Q28181608 | ||
| Mice devoid of PrP are resistant to scrapie | Q28249108 | ||
| Synthesis in E. coli of a polypeptide with human leukocyte interferon activity | Q28276363 | ||
| NEUROBIOLOGY:PrP's Double Causes Trouble | Q29544375 | ||
| The nature of small-airway obstruction in chronic obstructive pulmonary disease | Q29618682 | ||
| Immunoaffinity purification and neutralization of scrapie prion infectivity | Q33646402 | ||
| Quinacrine in possible or probable CJD: if you had suspected CJD would you be indifferent between placebo and quinacrine? | Q33808896 | ||
| Scrapie pathogenesis in subclinically infected B-cell-deficient mice | Q33823659 | ||
| Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells | Q33894673 | ||
| Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody | Q33930771 | ||
| Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease | Q33933969 | ||
| Absence of the prion protein homologue Doppel causes male sterility | Q34079215 | ||
| Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics | Q34190049 | ||
| Dominant-negative inhibition of prion replication in transgenic mice | Q34191612 | ||
| Prion pathogenesis in the absence of Toll-like receptor signalling | Q34227964 | ||
| A new variant of Creutzfeldt-Jakob disease in the UK. | Q34374893 | ||
| Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl. | Q34536351 | ||
| A cellular gene encodes scrapie PrP 27-30 protein | Q34557641 | ||
| Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin | Q34976098 | ||
| Dominant and recessive molecular changes in neuroblastomas | Q35246167 | ||
| Prions and the immune system: a journey through gut, spleen, and nerves | Q35622996 | ||
| Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes | Q35749282 | ||
| Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway | Q49018487 | ||
| Normal host prion protein necessary for scrapie-induced neurotoxicity | Q49160879 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Porphyrin and phthalocyanine antiscrapie compounds. | Q54061556 | ||
| Potent inhibition of scrapie-associated PrP accumulation by congo red | Q54131452 | ||
| PrPSc in mammary glands of sheep affected by scrapie and mastitis | Q57083648 | ||
| Chronic Lymphocytic Inflammation Specifies the Organ Tropism of Prions | Q57083652 | ||
| Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion | Q57083661 | ||
| PrP expression in B lymphocytes is not required for prion neuroinvasion | Q57083708 | ||
| Post-exposure prophylaxis after accidental prion inoculation | Q57083715 | ||
| A suspicious signature | Q57083722 | ||
| Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model | Q57092933 | ||
| Monoclonal antibodies inhibit prion replication and delay the development of prion disease | Q59053964 | ||
| The prion's progress | Q59097196 | ||
| Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides | Q59691802 | ||
| Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells | Q64447658 | ||
| Follicular dendritic cells in Hodgkin's disease | Q68192221 | ||
| Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells | Q70321863 | ||
| The AMOG/beta 2 subunit of Na,K-ATPase is not necessary for long-term survival of telencephalic grafts | Q71793621 | ||
| SCID mouse spleen does not support scrapie agent replication | Q72527353 | ||
| The immunophenotypic characterization of bovine lymphomas | Q73367789 | ||
| Mouse model to study the replication of primate foamy viruses | Q73615102 | ||
| Prp-c and Prp-Sc at the fetal-maternal interface | Q73684853 | ||
| Immune system-dependent and -independent replication of the scrapie agent | Q35855627 | ||
| Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
| Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies | Q36663046 | ||
| Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system | Q36688984 | ||
| Follicular dendritic cells in non-Hodgkin lymphomas: Localisation, characterisation and pathophysiological aspects | Q37105341 | ||
| A 'unified theory' of prion propagation | Q37257816 | ||
| Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions | Q37356800 | ||
| Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain | Q39683541 | ||
| Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain | Q39714572 | ||
| The impact of monoclonal antibodies on the study of human malignant melanoma | Q40109006 | ||
| Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease | Q40113593 | ||
| Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. | Q41064177 | ||
| Gene transfer using replication-defective human foamy virus vectors | Q41093346 | ||
| Transgenic and knockout mice in the study of neurodegenerative diseases | Q41143203 | ||
| Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice | Q41228406 | ||
| Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease | Q41652295 | ||
| Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene | Q41982232 | ||
| Identification of pol-related gene products of human foamy virus | Q42616568 | ||
| Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state | Q42675291 | ||
| Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice | Q42814832 | ||
| Prion (PrPSc)-specific epitope defined by a monoclonal antibody | Q42816365 | ||
| Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment | Q42816458 | ||
| Between cows and monkeys | Q43213308 | ||
| Prions. Sheep disease in human clothing | Q43486456 | ||
| Postexposure prophylaxis against prion disease with a stimulator of innate immunity | Q43490953 | ||
| Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein | Q43522858 | ||
| Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes | Q43838046 | ||
| Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease | Q44383471 | ||
| A third polypeptide associated with heavy and light chain subunits of class I HLA antigens in immune interferon-treated human melanoma cells | Q44703993 | ||
| Transmission of BSE by blood transfusion in sheep | Q45186151 | ||
| Degeneration of the cerebellar granule cell layer in transgenic mice expressing genes of human foamy virus | Q45756731 | ||
| Polyoma virus transforming protein associates with the product of the c-src cellular gene | Q45798405 | ||
| A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 | ||
| Antibodies inhibit prion propagation and clear cell cultures of prion infectivity | Q46161882 | ||
| 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal | Q47562788 | ||
| No propagation of prions in mice devoid of PrP. | Q48101222 | ||
| Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle | Q48101626 | ||
| Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease | Q48343268 | ||
| Expression of human immune interferon cDNA in E. coli and monkey cells | Q48405865 | ||
| Spongiform encephalopathies. The prion's perplexing persistence | Q48477602 | ||
| Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions | Q48479400 | ||
| Prion research: the next frontiers | Q48540005 | ||
| Identification of the end stage of scrapie using infected neural grafts. | Q48544566 | ||
| A crucial role for B cells in neuroinvasive scrapie. | Q48574532 | ||
| PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain | Q48630602 | ||
| Effectiveness of anthracycline against experimental prion disease in Syrian hamsters | Q48706421 | ||
| Coincident scrapie infection and nephritis lead to urinary prion excretion | Q48730761 | ||
| Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies | Q48800686 | ||
| Complement facilitates early prion pathogenesis | Q48930440 | ||
| P304 | page(s) | 257-355 | |
| P577 | publication date | 2007-01-01 | |
| P1476 | title | Chapter 7 A Neuropathologist's Diary |
Search more.